ECS vs RGT

ASX Healthcare sector comparison — updated 23 Jul 2026 — Healthcare sector

ECS

ECSBOTANIC FPO [ECS]

42LOW

RGT

ARGENTBIO FPO [RGT]

43LOW

Score Breakdown

ECS RGT
Technical
61
35
Catalyst
52
51
Sentiment
50
50
Fundamental
61
34
Momentum
57
44
Risk Gate
27
32

Key Metrics

ECS Metric RGT
$8.0MMarket Cap$5.4M
1.9MAvg Volume (20d)1.2M
N/AShort InterestN/A
$0.01052-Week High$0.320
$0.00352-Week Low$0.033
+10.0%Daily Change-7.4%
$0.005Reference Price$0.050
N/AROEN/A
N/AProfit MarginN/A

Active Signals

ECS Signals

MACD momentum is picking up steam
Trading above both moving averages — the trend is your friend here
Volume surging at 6.9x normal while price falls — heavy selling pressure
On a tear — up 10.0% over the last 5 days
Beating the Small Ords index — relative strength of 1.44, so it's outpacing the pack
Below the 200-day average — the long-term trend is still working against it
Strong cash runway (16 quarters)
4C filed 2026-07-19

RGT Signals

MACD momentum is losing steam
Took a hit — down 16.7% over the last 5 days
Beating the Small Ords index — relative strength of 1.41, so it's outpacing the pack
Below the 200-day average — the long-term trend is still working against it
Critical cash runway (0.8 quarters)
Strong revenue growth (+3905%)
Piotroski F-Score weak (2/9, low-confidence approx)
Near 52-week low (5% of range)

Ask Scout AI to compare ECS and RGT in depth.

Open Scout AI →

Track both stocks and 2,200+ more — Free

Daily AI-powered screening across every ASX small cap.

Open Screener

Related Comparisons

ECS vs RHY →ECS vs SNT →ECS vs TRU →ECS vs TTX →EIQ vs HMD →
ECS Full Analysis → RGT Full Analysis → Healthcare Sector → All Comparisons →
GENERAL INFORMATION ONLY. SmallCapData provides algorithmic screening data and does not constitute personal financial advice, a recommendation, or an offer to buy or sell any security. This content is produced by an algorithm, not a licensed financial adviser. You should consider seeking independent financial advice before making any investment decision. Past performance is not indicative of future results. Trading in small-cap securities carries a high degree of risk, including the risk of total loss of capital. The author may hold positions in mentioned securities. SmallCapData does not hold an Australian Financial Services Licence (AFSL).